Aethlon Medical, Inc.

Aethlon Medical submits Avian influenza treatment grant application

Published in Lab Business Week, May 14th, 2006

Aethlon Medical, Inc., (AEMD) has submitted an Avian influenza-related grant application entitled, "Extracorporeal Treatment of H5N1 Bird Flu Viral Sepsis."

The grant was submitted to the National Institutes of Health (NIH) to be directed to the National Institute of Allergy and Infectious Disease (NIAID) as a phase I Small Business Innovation Grant. The grant application discusses the deployment of the Aethlon Hemopurifier as a therapy to clear inflammatory cytokines, H5N1 Avian Flu virus and viral fragments that stimulate viral sepsis.

Grant collaborators include Leo L.M. Poon, Assistant professor at the University of Hong Kong, Department of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-05-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry